Literature DB >> 18448355

Hyalurondiase: both a tumor promoter and suppressor.

Vinata B Lokeshwar1, Marie G Selzer.   

Abstract

Originally termed as the "spreading factor", hyaluronidases (HAases) are present in a variety of toxins and venoms. For example, HAase is the virulent factor of beta-hemolytic Streptococci and it is also present in the venoms of snake, bee, wasp, scorpion, etc, where it aids in the spread of these venoms in the body. In mammals, testicular HAase present in the sperm acrosome is necessary for the fertilization of the ovum. Despite a lot of work on bacterial, invertebrate and testicular HAases, a connection between HAase and cancer was unequivocally established just over a decade ago and the functional significance of HAases in cancer was demonstrated just about a year ago. In this part of the review, we will focus on the recent advances in our understanding of the role of HAases in cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448355      PMCID: PMC2580740          DOI: 10.1016/j.semcancer.2008.03.008

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  91 in total

1.  The localisation of bovine sperm hyaluronidase.

Authors:  S F Gould; M H Bernstein
Journal:  Differentiation       Date:  1975-08-11       Impact factor: 3.880

2.  Hyaluronidase as additive to induction chemotherapy in advanced squamous cell carcinoma of the head and neck.

Authors:  J Klocker; H Sabitzer; W Raunik; S Wieser; J Schumer
Journal:  Cancer Lett       Date:  1998-09-11       Impact factor: 8.679

3.  L-Ascorbic acid 6-hexadecanoate, a potent hyaluronidase inhibitor. X-ray structure and molecular modeling of enzyme-inhibitor complexes.

Authors:  Alexander Botzki; Daniel J Rigden; Stephan Braun; Masatoshi Nukui; Sunnhild Salmen; Julia Hoechstetter; Günther Bernhardt; Stefan Dove; Mark J Jedrzejas; Armin Buschauer
Journal:  J Biol Chem       Date:  2004-08-18       Impact factor: 5.157

4.  A side by side comparison of cytology and biomarkers for bladder cancer detection.

Authors:  Grethchen L Schroeder; Maria-Fernanda Lorenzo-Gomez; Stefan H Hautmann; Martin G Friedrich; Sinan Ekici; Hartwig Huland; Vinata Lokeshwar
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

5.  Metaphylactic effect of mitomycin C with and without hyaluronidase after transurethral resection of bladder cancer: randomized trial.

Authors:  U Maier; G Baumgartner
Journal:  J Urol       Date:  1989-03       Impact factor: 7.450

6.  Assessment of contraceptive vaccines based on recombinant mouse sperm protein PH20.

Authors:  Christopher M Hardy; Gavin Clydesdale; Karen J Mobbs; Jenny Pekin; Megan L Lloyd; Clive Sweet; Geoffrey R Shellam; Malcolm A Lawson
Journal:  Reproduction       Date:  2004-03       Impact factor: 3.906

7.  Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

Authors:  Stefan Hautmann; Marieta Toma; Maria Fernanda Lorenzo Gomez; Martin G Friedrich; Torsten Jaekel; Uwe Michl; Gretchen L Schroeder; Hartwig Huland; Klaus-Peter Juenemann; Vinata B Lokeshwar
Journal:  Eur Urol       Date:  2004-10       Impact factor: 20.096

8.  Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.

Authors:  Sinan Ekici; Wolfgang H Cerwinka; Robert Duncan; Pablo Gomez; Francisco Civantos; Mark S Soloway; Vinata B Lokeshwar
Journal:  Int J Cancer       Date:  2004-10-20       Impact factor: 7.396

9.  Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro.

Authors:  Shane K Green; Giulio Francia; Ciro Isidoro; Robert S Kerbel
Journal:  Mol Cancer Ther       Date:  2004-02       Impact factor: 6.261

Review 10.  Sperm specific proteins-potential candidate molecules for fertility control.

Authors:  Anil Suri
Journal:  Reprod Biol Endocrinol       Date:  2004-03-10       Impact factor: 5.211

View more
  26 in total

1.  Evidence of epigenetic regulation of the tumor suppressor gene cluster flanking RASSF1 in breast cancer cell lines.

Authors:  Erika da Costa Prando; Luciane Regina Cavalli; Cláudia Aparecida Rainho
Journal:  Epigenetics       Date:  2011-12       Impact factor: 4.528

Review 2.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

3.  Fluorescence detection of hyaluronidase.

Authors:  Rafal Fudala; Mark E Mummert; Zygmunt Gryczynski; Ignacy Gryczynski
Journal:  J Photochem Photobiol B       Date:  2011-06-12       Impact factor: 6.252

4.  Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model.

Authors:  Barbara M Mueller; Ingrid U Schraufstatter; Valentina Goncharova; Tatiana Povaliy; Richard DiScipio; Sophia K Khaldoyanidi
Journal:  Mol Cancer Ther       Date:  2010-09-10       Impact factor: 6.261

Review 5.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

6.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

7.  Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.

Authors:  Christopher S Gomez; Pablo Gomez; Judith Knapp; Merce Jorda; Mark S Soloway; Vinata B Lokeshwar
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

Review 8.  Clinical Applications of Hyaluronidase.

Authors:  Gregor Cornelius Weber; Bettina Alexandra Buhren; Holger Schrumpf; Johannes Wohlrab; Peter Arne Gerber
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.

Authors:  Frederikke Lihme Egerod; Annette Bartels; Niels Fristrup; Michael Borre; Torben F Ørntoft; Martin B Oleksiewicz; Nils Brünner; Lars Dyrskjøt
Journal:  BMC Cancer       Date:  2009-10-30       Impact factor: 4.430

Review 10.  Targeting hyaluronic acid family for cancer chemoprevention and therapy.

Authors:  Vinata B Lokeshwar; Summan Mirza; Andre Jordan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.